Record Genomic Data Access Auditably in Vaults
Sector: Quaternary sector · Industry: Biotechnology and genetic research · Organisation: Genomes.io, GenomesDAO · Maturity level: Production
Genomes.io and GenomesDAO operate a secure DNA vault service allowing individuals to store sequencing data in encrypted repositories and authorize research access. Every query executed by external research teams is immutably documented in an Ethereum-based audit log without ever releasing raw genomic files. The platform has already executed commercial research studies, enabling privacy-preserving biomedical analysis with cryptographic access verification.
Documentation status
- Project status: Production — The platform is in operational production with completed commercial research studies.
- Evidence: Evidence medium
- Editorial review: pending
Description
Genomes.io and GenomesDAO use a blockchain solution to monitor access to sensitive genetic data transparently and immutably. Instead of centralising genome sequences on external servers, the data remain encrypted in secure personal data vaults. Researchers submit targeted computational queries to the data vaults, while the blockchain irrevocably logs every authorisation and access step.
Conventional genomics models often rely on centralised biobanks or platforms where donors relinquish control over their raw data after initial sequencing. Genomes.io’s model addresses this security risk through an architecture linking personal data vaults with a tamper-proof Ethereum audit log. External research organisations never receive unencrypted raw files but perform only deterministic queries over authorised parameters. All interactions and access permissions are validated decentrally and permanently recorded in the blockchain ledger. This approach has already successfully and data-protection-compliantly handled real, remunerated studies on genetic risk factors and severe disease courses such as COVID-19.
Perspectives
B2B — organisations perspective
For research-focused pharmaceutical and biotech companies, the architecture offers verified access to validated cohorts without regulatory risks from unauthorized data possession. Every query process is tamper-resistantly documented, massively simplifying compliance and audit procedures in clinical study projects.
B2C — consumers perspective
End users retain full control over their sequenced genome and can make individual access decisions via a mobile application. They can trace exactly which research project conducted a query at what time and receive direct compensation for it.
Employees perspective
Staff in research labs and bioinformatics departments work via clearly defined interfaces with reproducible datasets. Automatic access checks reduce manual administrative effort for consent verifications in daily study operations.
Benefits
General
- Tamper-proof logging of all data queries
- Increased data sovereignty without sharing unencrypted raw genome data
- Higher trust basis for participation in scientific studies
B2B — organisations
- Complete audit trail security for regulatory compliance requirements
- Legally compliant access to high-quality genetic study cohorts
B2C — consumers
- Full control over the use of one’s own genetic profile
- Transparent real-time tracking of every data usage
Employees
- Elimination of manual proof and approval processes for study leaders
- Standardised interfaces for reproducible bioinformatic queries
Challenges
General
- Complexity in integrating cryptographic vault architectures with bioinformatic analysis tools
- Scaling on-chain transaction costs with high-frequency query logics
B2B — organisations
- Required adaptation of established in-house analysis pipelines to protected query environments
B2C — consumers
- Barriers in understanding cryptographic key management and mobile data authorisation
Employees
- Training needs in handling encrypted data interfaces and wallet identities
Technology foundation
The solution combines client-side encryption and personal data vaults with the Ethereum blockchain, which serves as an immutable protocol for access rights and audit trails.
Implementation examples
Genomes.io DNA Vault and Research Audit Log
Traditional genetic databases suffer from a lack of user transparency and high legal risks in protecting sensitive health data from unauthorised access.
Genomes.io implemented encrypted DNA vaults with an Ethereum-based audit trail for tamper-proof logging of study queries.
The organisation Genomes.io developed a platform where genetic data is stored in isolated, encrypted containers. Researchers send specific computational queries to these vaults instead of gaining access to the raw sequencing files. Every query step is immutably recorded on the Ethereum blockchain, which has already been used productively in real studies on COVID-19 courses and behavioural traits.
Prevention of uncontrolled sharing of raw genetic data and ensuring seamless verifiable consent and access management.
Tags
Genomics, Audit Trail, Data Security, Smart Contracts, Ethereum